Jorge Nieva
University of Southern California
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jorge Nieva as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:47 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04640259 · Epidemiology of Young Lung Cancer - SurveyAddario Lung Cancer Medical Institute · completed · NSCLC · principal investigator
- N/ANCT03098277 · Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing ChemotherapyUniversity of Southern California · completed · Solid Neoplasm · principal investigator
- Ph2NCT03049618 · Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475University of Southern California · completed · ALK Gene Mutation, BRAF Gene Mutation, EGFR Gene Mutation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Research Training and Education CoordinationP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Josh Neman-Ebrahim · fiscal years 2000 to 2026Named on NCT03098277, NCT03049618
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:47 UTC. The ranking covers the 200 most relevant of 18 PubMed records, and a shared surname and initials can bring in a namesake. All 18 on PubMed
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.Nature · 2011466 citationsRCR 10.9
- AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.N Engl J Med · 2006395 citationsRCR 10.5
- Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer.J Thorac Oncol · 2019153 citationsRCR 5.5
- Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.Blood · 2003118 citationsRCR 2.4
- 100 citationsRCR 2.7
- 82 citationsRCR 2.1
- 59 citationsRCR 2.5
- Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.JAMA Oncol · 202348 citationsRCR 3.6
- A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.Oncologist · 201647 citationsRCR 1.4
- 46 citationsRCR 1.5